Adial Pharmaceuticals ADIL Insider Ownership

Updated Oct 5, 2026

Over the trailing 12 months, ADIL insiders bought $106,329 worth of shares in open-market trades, with no open-market sales.

• Among Adial Pharmaceuticals' insiders, the largest open-market purchases in the past 12 months were by Coastlands Capital LP (10% owner), totaling $106,329, most recently on July 16, 2026.
• Business Quant data puts insider holdings in ADIL at 792.65K shares across insiders' latest Form 4 filings, or 17.15% of the 4.62Mn shares outstanding; that total is up 1.92% from 777.72K shares at the end of Q2 2026.
• Indirect holdings, through trusts, partnerships, family members and other entities, make up 49.51% (392.47K shares) of Adial Pharmaceuticals' insider total, with the other 50.49% (400.19K shares) held directly.
• Per Business Quant, 8 insiders of ADIL hold shares, counting officers, directors and 10% owners who have filed a Form 4 in the past two years.
• Adial Pharmaceuticals' top three insider holders by shares held are Coastlands Capital LP (10% owner, 388.31K shares), Matt Davidson (Chief Development Officer, 300.92K shares) and Cary J. Claiborne (Chief Executive Officer, 40.42K shares).
• Coastlands Capital LP alone accounts for 48.99% of the shares held by Adial Pharmaceuticals insiders.
• In the last 12 months, 12 Form 4 filings with transactions in ADIL stock came from 9 insiders.
• The insider holdings and trades above for Adial Pharmaceuticals reflect Form 4 filings through September 21, 2026.